Related Experiment Video
Updated: Mar 17, 2026

06:28
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
7.3K
Can prepartum thromboelastometry-derived parameters and fibrinogen levels really predict postpartum hemorrhage?
Journal of Perinatal Medicine
|July 22, 2016
Summary
Prepartum coagulation tests like ROTEM® and fibrinogen levels do not predict postpartum hemorrhage (PPH). Primiparity and urgent cesarean delivery were identified as key risk factors for PPH.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Anesthesiology
Background:
- Postpartum hemorrhage (PPH) is a leading cause of maternal mortality.
- Decreased postpartum rotational thromboelastometry (ROTEM®) parameters and fibrinogen levels are linked to PPH.
- The predictive value of prepartum coagulation parameters for PPH is not well understood.
Purpose of the Study:
- To investigate the predictive capability of prepartum rotational thromboelastometry (ROTEM®) parameters and fibrinogen levels for postpartum hemorrhage (PPH).
Main Methods:
- A prospective observational pilot study involving 217 healthy pregnant women.
- Measurement of maximum clot firmness (FIBTEM-MCF) and fibrinogen levels (Fbgpre) upon admission and within 1 hour postpartum.
- Blood loss assessment using calibrated drapes, with PPH defined as ≥500 mL blood loss.
Main Results:
- No significant difference in median FIBTEM-MCF or mean Fbgpre between women with and without PPH.
- Prepartum coagulation parameters (FIBTEM-MCF, Fbgpre) did not correlate with postpartum blood loss.
- FIBTEM-MCF and Fbgpre showed no significant predictive power for PPH (AUCs 0.52 and 0.53, respectively).
- Primiparity (OR 4.27) and urgent cesarean section (OR 2.77) emerged as independent predictors of PPH.
Conclusions:
- Prepartum ROTEM® parameters and fibrinogen levels do not predict postpartum hemorrhage (PPH).
- Primiparity and urgent cesarean delivery are significant risk factors for PPH.
- Larger, adequately powered studies are required to validate these findings.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
454
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
454
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Clot Retraction and Fibrinolysis
9.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.9K

